echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > What are the most authoritative children's hospitals in the UK, what cutting-edge therapies for the treatment of pediatric neuroblastoma?

    What are the most authoritative children's hospitals in the UK, what cutting-edge therapies for the treatment of pediatric neuroblastoma?

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Neuroblastoma is one of the most common extracranial solid tumors in children, mainly in infants and young children
    .
    According to the different high-risk factors, neuroblastoma can be divided into low-risk groups, intermediate-risk groups, and high-risk groups
    .
    Different levels of risk neuroblastoma are treated differently and have different
    prognosis.

     

    According to data from Great Ormond Street Hospital for Children (GOSH), the 5-year survival rate of neuroblastoma in the low- and intermediate-risk groups is 80%-95% after reasonable treatment; The 5-year survival rate for neuroblastoma in high-risk groups is 50% to 60%.

    So, how should neuroblastoma be treated?

     

    ▲Source: Maker stickers

     

    How are different neuroblastomas treated?

     

    Treatment options for different grades of neuroblastoma vary depending on the condition:

     

     

     

     

    Advanced therapy for neuroblastoma

     

    In recent years, with the continuous improvement of medical technology, innovative therapies for neuroblastoma have gradually increased, which has made great contributions
    to prolonging the survival of neuroblastoma patients.

     

    Taking Great Ormond Street Hospital (GOSH) as an example, the current advanced therapies for the treatment of neuroblastoma at Great Ormond Street Hospital include:

     

     

     

     

     

     

    In addition, Great Ormond Street Hospital (GOSH) in the United Kingdom also conducts three innovative studies for neuroblastoma, but it should be noted that the research is still in the experimental stage, not open to the public, and has not entered clinical application
    .

     

    1

    In 2020, a phase I clinical trial conducted by Great Ormond Street Hospital for Children (GOSH) and the Great Ormond Street Institute for Child Health (UCL GOS ICH) at University College London showed that CAR-T cell therapy showed good early results in childhood neuroblastoma, opening the door
    to further clinical trials of this approach.

    2

    In 2021, researchers at Great Ormond Street Hospital for Children (GOSH) in the United Kingdom found that although the clinical manifestations of neuroblastoma vary widely, a major neuroblastoma cell type, sympathoblasts, is present in all patients
    .
    Sympathetic neuroblasts are expected to be drug targets for the treatment of neuroblastoma, leading to the development of more effective and innovative therapies
    .

     

    ▲Neuroblastoma cells, source: Great Ormond Street Children's Hospital, UK

    3

    In 2022, researchers at Great Ormond Street Hospital for Children (GOSH) in the UK are prescribing a new surgical technique
    that can improve the effectiveness of neuroblastoma treatment.
    These technological innovations are designed to help surgeons illuminate living cancer cells during surgery using a special molecule called a "fluorophores" to accurately see the edges of
    cancer tissue in the body.
    This "color-coded" procedure can help improve tumor visualization in childhood cancer surgery, remove as much residual tumor as possible, and remove cancer cells that are "invisible" to the naked eye, thereby maximizing the effectiveness and safety of neuroblastoma surgery
    .

     

    Great Ormond Street Children's Hospital, UK

     

    Great Ormond Street Hospital for Children (GOSH) is one of the four authoritative children's hospitals in the world and one of the three largest treatment centres for children with cancer/leukaemia in the world.

    The Department of Hematology and Oncology at Great Ormond Street Hospital in the UK and University College Hospital London (UCLH) have partnered to become Europe's largest centre for
    paediatric and adolescent cancer.
    The department is designed to treat the rarest and most complex childhood cancers, with overall survival rates for hematological and oncological diseases comparable to the best results internationally
    .

     

    ▲Source: Great Ormond Street Children's Hospital, UK

     

    As the UK's leading centre for many different types of malignant and non-malignant pediatric oncology diseases, the Department of Hematology and Oncology at Great Ormond Street Hospital has saved countless lives by providing more effective and personalised treatment options for countless pediatric patients
    .

     

    Magnolia Ark has established an in-depth cooperative relationship with Great Ormond Street Hospital for Children, UK, which can provide medical treatment and remote consultation services for children with neuroblastoma and improve the prognosis
    of children.
    If you want to know more about the treatment of neuroblastoma, or want to make an appointment at Great Ormond Street Hospital for Children, you can call the hotline at 400-081-6600 or add WeChat DrHopeNoah to contact us
    .

     

    Reviewed: Great Ormond Street Hospital for Children, UK

     

    Reference source: Great Ormond Street Hospital for Children, UK

    style="box-sizing: border-box;" _msthash="320097" _msttexthash="8586461"> style="box-sizing: border-box;" _msthash="320098" _msttexthash="7851077"> style="box-sizing: border-box;" _msthash="320099" _msttexthash="8227817"> _msthidden="9">

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.